['INTERACTING DRUG', 'INTERACTION', 'MULTIVALENT\xc2\xa0CATION-CONTAINING\xc2\xa0PRODUCTS\xc2\xa0INCLUDING\xc2\xa0ANTACIDS,\xc2\xa0METAL\xc2\xa0CATIONS\xc2\xa0OR\xc2\xa0DIDANOSINE', 'ABSORPTION\xc2\xa0OF\xc2\xa0LEVOFLOXACIN\xc2\xa0IS\xc2\xa0DECREASED\xc2\xa0WHEN\xc2\xa0THE\xc2\xa0TABLET\xc2\xa0FORMULATION\xc2\xa0IS\xc2\xa0TAKEN\xc2\xa0WITHIN\xc2\xa02\xc2\xa0HOURS\xc2\xa0OF\xc2\xa0THESE\xc2\xa0PRODUCTS.\xc2\xa0( 2.4 , 7.1 )', 'WARFARIN', 'EFFECT\xc2\xa0MAY\xc2\xa0BE\xc2\xa0ENHANCED.\xc2\xa0MONITOR\xc2\xa0PROTHROMBIN\xc2\xa0TIME,\xc2\xa0INR,\xc2\xa0WATCH\xc2\xa0FOR\xc2\xa0BLEEDING\xc2\xa0( 7.2 )', 'ANTIDIABETIC\xc2\xa0AGENTS', 'CAREFULLY\xc2\xa0MONITOR\xc2\xa0BLOOD\xc2\xa0GLUCOSE\xc2\xa0( 5.11 , 7.3 )']